JP2025504894A5 - - Google Patents
Info
- Publication number
- JP2025504894A5 JP2025504894A5 JP2024543843A JP2024543843A JP2025504894A5 JP 2025504894 A5 JP2025504894 A5 JP 2025504894A5 JP 2024543843 A JP2024543843 A JP 2024543843A JP 2024543843 A JP2024543843 A JP 2024543843A JP 2025504894 A5 JP2025504894 A5 JP 2025504894A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- seq
- fragment according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263302639P | 2022-01-25 | 2022-01-25 | |
| US63/302,639 | 2022-01-25 | ||
| PCT/US2023/061136 WO2023147292A2 (en) | 2022-01-25 | 2023-01-24 | Anaplastic lymphoma kinase antibodies and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025504894A JP2025504894A (ja) | 2025-02-19 |
| JP2025504894A5 true JP2025504894A5 (cg-RX-API-DMAC7.html) | 2026-01-30 |
Family
ID=87472498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024543843A Pending JP2025504894A (ja) | 2022-01-25 | 2023-01-24 | 未分化リンパ腫キナーゼ抗体およびその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250101134A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4469486A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025504894A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240135653A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118696064A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023213840A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3248976A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024009078A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023147292A2 (cg-RX-API-DMAC7.html) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3066118B1 (en) * | 2013-11-06 | 2020-01-08 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Alk antibodies, conjugates, and chimeric antigen receptors, and their use |
| US11091559B2 (en) * | 2015-08-27 | 2021-08-17 | Celldex Therapeutics, Inc. | Anti-ALK antibodies and methods for use thereof |
| WO2019075433A1 (en) * | 2017-10-13 | 2019-04-18 | Adimab, Llc | ANTIBODIES AGAINST SYNCYTIAL RESPIRATORY VIRUS AND METHODS FOR THEIR GENERATION AND USE |
| CN112794914B (zh) * | 2019-11-14 | 2022-09-16 | 深圳华大生命科学研究院 | 一种基于噬菌体展示技术开发的alk纳米抗体及其应用 |
| CA3168133A1 (en) * | 2020-01-28 | 2021-08-05 | The Children's Medical Center Corporation | Anaplastic lymphoma kinase chimeric antigen receptors and methods of use |
-
2023
- 2023-01-24 CN CN202380018798.XA patent/CN118696064A/zh active Pending
- 2023-01-24 US US18/729,531 patent/US20250101134A1/en active Pending
- 2023-01-24 MX MX2024009078A patent/MX2024009078A/es unknown
- 2023-01-24 JP JP2024543843A patent/JP2025504894A/ja active Pending
- 2023-01-24 EP EP23747781.5A patent/EP4469486A4/en active Pending
- 2023-01-24 CA CA3248976A patent/CA3248976A1/en active Pending
- 2023-01-24 WO PCT/US2023/061136 patent/WO2023147292A2/en not_active Ceased
- 2023-01-24 AU AU2023213840A patent/AU2023213840A1/en active Pending
- 2023-01-24 KR KR1020247027390A patent/KR20240135653A/ko active Pending